The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
Brief Report
PreviousPrevious
Volume 357:897-904 August 30, 2007 Number 9
NextNext

Luteinizing Hormone Beta Mutation and Hypogonadism in Men and Women
Adriana Lofrano-Porto, M.D., Gustavo Barcelos Barra, Pharm.D., Leonardo Abdala Giacomini, Paula Pires Nascimento, Ana Claudia Latronico, M.D., Luiz Augusto Casulari, M.D., and Francisco de Assis da Rocha Neves, M.D.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-PowerPoint Slide Set
-Supplementary Material

Commentary
-Editorial
 by Bhasin, S.

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
SUMMARY

Selective luteinizing hormone deficiency due to mutations in the luteinizing hormone beta-subunit gene (LHB) is a rare cause of hypogonadism. We describe the clinical features of a consanguineous family in which three siblings, two men and one woman, had hypogonadism related to isolated luteinizing hormone deficiency. These subjects have a newly discovered homozygous mutation of a 5' splice site in LHB: IVS2+1G->C. This mutation disrupts the splicing of messenger RNA (mRNA), generating a gross abnormality in the processing of the luteinizing hormone beta-subunit mRNA, which abrogates the secretion of luteinizing hormone. We also determined that the female phenotype of this LHB mutation is characterized by normal pubertal development, secondary amenorrhea, and infertility.


Source Information

From the Section of Endocrinology, University Hospital of Brasília, Faculty of Medicine (A.L.-P., L.A.G., P.P.N., L.A.C.), and the Molecular Pharmacology Laboratory, Faculty of Health Sciences (G.B.B., F.A.R.N.), University of Brasília, Brasília; the Sabin Institute and Laboratory of Clinical Analysis, Brasília (G.B.B.); and the Developmental Endocrinology Unit, Hormone and Molecular Genetic Laboratory, São Paulo University Medical School, São Paulo (A.C.L.) — all in Brazil.

Drs. Lofrano-Porto and Barra and Drs. Casulari and Neves contributed equally to this article.

Address reprint requests to Dr. Lofrano-Porto at the Hospital Universitário de Brasília, Laboratório de Farmacologia Molecular, Campus Universitário Darcy Ribeiro, Caixa Postal 04473, CEP 70.919-970, Brasília DF, Brazil, or at adlofrano{at}unb.br.

Full Text of this Article


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.